Scientific Presentations
The following poster and oral scientific data presentations represent the work of Medtronic employees and/or independent investigators using Medtronic devices in their research. Poster presentations will be available to all attendees for viewing with an option to query presenters throughout the conference.
InPen™ Smart Insulin Pen
- "Impact of InPen™ smart insulin pen use on real-world glycemic and insulin dosing outcomes in individuals with poorly controlled diabetes" – oral presentation by Robert Vigersky, M.D. on
Sunday, June 27 at6:15 p.m. ET . - "Glycemic outcomes of new InPen™ smart insulin pen users who received virtual onboarding" – poster presentation by
Madison Smith , Ph.D., R.N.
Medtronic Extended Infusion Set*
- "Infusion Set Survival and Performance During the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial" – poster presentation by
Bruce Buckingham , M.D. - "Patient Reported Satisfaction During the Medtronic Extended-Wear Infusion Set (EWIS) Pivotal Trial" – poster presentation by
Ron Brazg , M.D., FACE.
Hybrid Closed-Loop (HCL)
- "Closed-Loop Increases Time-in-Range in Older Adults with Type 1 Diabetes Compared with Sensor- Augmented Pump Therapy: A Randomized Crossover Trial" – independent oral presentation by
Sybil McAuley , MBBS, Ph.D., FRACP, onSunday, June 27 at4:30 p.m. ET . - "Durable insulin pumps vs. multiple daily injections for type 1 diabetes: Healthcare utilization and A1C" – poster presentation by
Mona Shah , M.S.
Advanced Hybrid Closed-Loop (AHCL)*
- "Robust glycemic outcomes after MiniMed™ Advanced Hybrid Closed-Loop (AHCL) System use regardless of previous therapy" – poster presentation by
John Shin , Ph.D., MBA.
Conference Events
Medtronic will host a product theater and offer two on-demand Learning Bytes that will focus on the outcomes to date with InPen™ and the MiniMed™ 770G and MiniMed™ 780G systems. The product theatre will also feature a patient panel and a look at the Medtronic technology roadmap.
- "Shared Decision with Diabetes Technology" - product theater live on
Friday, June 25 at10:00 a.m. ET then available on-demand. Speakers and topics to be presented will include:
M.A., R.D., CDCES, FADCES, head of clinical advocacy, | Introduction and Insulin 100 |
PharmD, BCPS, BC-ADM, CDCES, FADCES | Smart MDI Therapy: Smart Insulin Pens and CGM are Improving MDI Therapy |
Robert Vigersky, M.D. and chief medical officer, global medical & clinical affairs, | MiniMed™ 770G and 780G Systems: Proven Outcomes in Clinical Trials and Real-World Data in Pediatric and Adult Populations |
PharmD, BCPS, BC-ADM, CDCES, FADCES | |
vice president, product innovation, | Looking Toward the Future: Next Steps in the Advancement of Closing the Loop |
M.A., R.D., CDCES, FADCES, head of clinical advocacy, | Q & A |
- "Tips for Success When Transitioning Patient from Multiple Daily Injection (MDI) to Insulin Pump Therapy" – on-demand Learning Byte presented by
Laurie Jung , R.D., CDCES, opening onThursday, June 24 at8:00 a.m. ET . - "InPen™ Smart Insulin Pen: Product Features and Overview" – on-demand Learning Byte presented by
Diana Isaacs , PharmD, BCPS, BC-ADM, CDCES, FADCES, opening onThursday, June 24 at8:00 a.m. ET .
In addition, the Medtronic 24-hour virtual exhibit booth will feature the company's full portfolio of diabetes technologies, spanning smart MDI therapy with the InPen smart insulin pen system and advanced insulin pump technology like the MiniMed 770G insulin pump system. The exhibit will also highlight personalized service and support offerings, including those that enable remote and virtual care.
About the Diabetes Business at Medtronic (www.medtronicdiabetes.com)
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care, and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
About Medtronic
*CAUTION – Investigational device. Limited by
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the
Contacts:
Public Relations
+1-818-576-5611
Investor Relations
+1-763-505-4626
View original content to download multimedia:http://www.prnewswire.com/news-releases/medtronic-announces-real-world-data-on-inpen-and-extended-infusion-set-pivotal-trial-data-at-the-american-diabetes-association-81st-scientific-sessions-301317852.html
SOURCE
© Canada Newswire, source